Search results
Results from the WOW.Com Content Network
The Moderna COVID‑19 vaccine, sold under the brand name Spikevax, is a COVID-19 vaccine developed by the American company Moderna, the United States National Institute of Allergy and Infectious Diseases (NIAID), and the Biomedical Advanced Research and Development Authority (BARDA).
The updated Covid vaccines should be more accessible, experts say. Saturday 16 September 2023 21:00, Maggie O’Neill. The cost of the new Covid vaccines may prohibit some people from getting them ...
On Monday, the U.S. Food and Drug Administration approved new mRNA boosters from Moderna and Pfizer. Approval for another booster from Novavax is likely forthcoming. Approval for another booster ...
The updated doses from Pfizer and Moderna will target KP.2 while the third option, from Novavax, will target JN.1, NBC News reports. ... When should you get the COVID booster? If approved this ...
New Covid boosters from Pfizer and Moderna designed to target the XBB.1.5 subvariant have been approved by the US Food and Drug Administration and are expected to be made available later this week.
mRNA-1283 is a COVID-19 vaccine candidate developed by Moderna. [ 2 ] [ 3 ] Compared to prior mRNA vaccines, this candidate has a storage temperature of 2-5 °C, compatible with vaccine storage in a standard refrigerator, rather than low temperature freezers. [ 4 ]
The FDA authorizes the first bivalent COVID-19 booster for ages 5-11. ... CDC approves Pfizer, Moderna's COVID-19 boosters for ages 5 and up. Anjalee Khemlani. October 12, 2022 at 10:24 AM.
The COVID-19 vaccines the FDA has authorized or approved to date, excluding the updated boosters, are considered “monovalent” and include “a component from the original strain of SARS-CoV-2 ...